380 related articles for article (PubMed ID: 20735863)
1. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.
Castelino FV; Varga J
Arthritis Res Ther; 2010; 12(4):213. PubMed ID: 20735863
[TBL] [Abstract][Full Text] [Related]
2. Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases.
Chiu YH; Spierings J; de Jong PA; Hoesein FM; Grutters JC; van Laar JM; Voortman M
Respir Med; 2021 Oct; 187():106579. PubMed ID: 34438351
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 1,044 Chinese Patients.
Hu Y; Wang LS; Wei YR; Du SS; Du YK; He X; Li N; Zhou Y; Li QH; Su YL; Zhang F; Shen L; Weng D; Brown KK; Li HP
Chest; 2016 Jan; 149(1):201-8. PubMed ID: 26447566
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
Singh P; Thakur B; Mohapatra AK; Padhan P
Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
[TBL] [Abstract][Full Text] [Related]
5. Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study.
Choi WI; Lee DY; Choi HG; Lee CW
Respir Res; 2019 Jun; 20(1):117. PubMed ID: 31182103
[TBL] [Abstract][Full Text] [Related]
6. Management of interstitial lung disease associated with connective tissue disease.
Mathai SC; Danoff SK
BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
[TBL] [Abstract][Full Text] [Related]
7. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
8. Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements.
Kuwana M; Bando M; Kawahito Y; Sato S; Suda T; Kondoh Y;
Expert Rev Respir Med; 2023 Jan; 17(1):71-80. PubMed ID: 36786105
[TBL] [Abstract][Full Text] [Related]
9. Assessment and management of connective tissue disease-associated interstitial lung disease.
Fischer A; Chartrand S
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):2-21. PubMed ID: 26237351
[TBL] [Abstract][Full Text] [Related]
10. Management of connective tissue disease-associated interstitial lung disease.
Chartrand S; Fischer A
Rheum Dis Clin North Am; 2015 May; 41(2):279-94. PubMed ID: 25836643
[TBL] [Abstract][Full Text] [Related]
11. Prediction of long-term mortality by using machine learning models in Chinese patients with connective tissue disease-associated interstitial lung disease.
Sun D; Wang Y; Liu Q; Wang T; Li P; Jiang T; Dai L; Jia L; Zhao W; Cheng Z
Respir Res; 2022 Jan; 23(1):4. PubMed ID: 34996461
[TBL] [Abstract][Full Text] [Related]
12. Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
Saketkoo LA; Mittoo S; Frankel S; LeSage D; Sarver C; Phillips K; Strand V; Matteson EL; ;
J Rheumatol; 2014 Apr; 41(4):792-8. PubMed ID: 24488412
[TBL] [Abstract][Full Text] [Related]
13. New treatment paradigms for connective tissue disease-associated interstitial lung disease.
Kouranos V; Miranda G; Corte TJ; Renzoni EA
Curr Opin Pulm Med; 2018 Sep; 24(5):453-460. PubMed ID: 30020142
[TBL] [Abstract][Full Text] [Related]
14. [Recommendations for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease in China].
Zou QH; Lu YW; Zhou JG; Liu XX; Li MT; Zhao Y
Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1217-1223. PubMed ID: 36323562
[TBL] [Abstract][Full Text] [Related]
15. Interstitial lung disease in connective tissue disease--mechanisms and management.
Wells AU; Denton CP
Nat Rev Rheumatol; 2014 Dec; 10(12):728-39. PubMed ID: 25266451
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D levels are prognostic factors for connective tissue disease associated interstitial lung disease (CTD-ILD).
Gao Y; Zhao Q; Qiu X; Zhuang Y; Yu M; Dai J; Cai H; Yan X
Aging (Albany NY); 2020 Mar; 12(5):4371-4378. PubMed ID: 32167486
[TBL] [Abstract][Full Text] [Related]
17. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.
Koo SM; Uh ST
Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913
[TBL] [Abstract][Full Text] [Related]
18. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.
Pugashetti JV; Khanna D; Kazerooni EA; Oldham J
Immunol Allergy Clin North Am; 2023 May; 43(2):411-433. PubMed ID: 37055096
[TBL] [Abstract][Full Text] [Related]
19. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.
Pugashetti JV; Khanna D; Kazerooni EA; Oldham J
Rheum Dis Clin North Am; 2024 Aug; 50(3):439-461. PubMed ID: 38942579
[TBL] [Abstract][Full Text] [Related]
20. The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies.
Tseng CC; Sung YW; Chen KY; Wang PY; Yen CY; Sung WY; Wu CC; Ou TT; Tsai WC; Liao WT; Chen CJ; Lee SC; Chang SJ; Yen JH
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
